GB0400802D0 - Compounds for the treatment of disease - Google Patents
Compounds for the treatment of diseaseInfo
- Publication number
- GB0400802D0 GB0400802D0 GB0400802A GB0400802A GB0400802D0 GB 0400802 D0 GB0400802 D0 GB 0400802D0 GB 0400802 A GB0400802 A GB 0400802A GB 0400802 A GB0400802 A GB 0400802A GB 0400802 D0 GB0400802 D0 GB 0400802D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- disease
- compounds
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0400802A GB0400802D0 (en) | 2004-01-14 | 2004-01-14 | Compounds for the treatment of disease |
PCT/GB2005/000119 WO2005067931A2 (en) | 2004-01-14 | 2005-01-14 | Dopamine uptake inhibitors for the treatment of neurological disease |
PCT/GB2005/000118 WO2005067930A2 (en) | 2004-01-14 | 2005-01-14 | Serotonin receptor antagonists for the treatment of neurological disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0400802A GB0400802D0 (en) | 2004-01-14 | 2004-01-14 | Compounds for the treatment of disease |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0400802D0 true GB0400802D0 (en) | 2004-02-18 |
Family
ID=31726178
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0400802A Ceased GB0400802D0 (en) | 2004-01-14 | 2004-01-14 | Compounds for the treatment of disease |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0400802D0 (en) |
WO (2) | WO2005067930A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007065713A2 (en) * | 2005-12-08 | 2007-06-14 | Axxonis Pharma Gmbh | Use of 8-alpha-ergolines for the treatment of traumatic brain disorders |
US20120028992A1 (en) * | 2010-08-02 | 2012-02-02 | Brown Arthur M | Pharmaceutical compositions for terminating acute episodes of cardiac arrhythmia, restoring sinus rhythm, preventing recurrence of cardiac arrhythmia and/or maintaining normal sinus rhythm in mammals |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
JP2016503795A (en) * | 2012-12-21 | 2016-02-08 | マップ ファーマシューティカルズ インコーポレイテッド | Novel methysergide derivatives |
WO2015119938A1 (en) * | 2014-02-05 | 2015-08-13 | Chanrx Corporation | Pharmaceutical compositions for terminating acute episodes of cardiac arrhythmia, restoring sinus rhythm, preventing recurrence of cardiac arrhythmia, and/or maintaining normal sinus rhythm in mammals |
GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
WO2020212948A1 (en) | 2019-04-17 | 2020-10-22 | Compass Pathfinder Limited | Methods of treating neurocognitive disorders, chronic pain and reducing inflammation |
GB201911024D0 (en) * | 2019-08-01 | 2019-09-18 | Beckley Found | Compounds for use in a method of treating or preventing neurological and/or psychiatric disorders |
-
2004
- 2004-01-14 GB GB0400802A patent/GB0400802D0/en not_active Ceased
-
2005
- 2005-01-14 WO PCT/GB2005/000118 patent/WO2005067930A2/en active Application Filing
- 2005-01-14 WO PCT/GB2005/000119 patent/WO2005067931A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2005067930A3 (en) | 2006-02-23 |
WO2005067931A2 (en) | 2005-07-28 |
WO2005067930A2 (en) | 2005-07-28 |
WO2005067931A3 (en) | 2005-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200808178B (en) | Imidazolothiazole compounds for the treatment of disease | |
IL227841A0 (en) | Dihydropteridinones for the treatment of cancer diseases | |
IL195571A0 (en) | Compounds for the treatment of periodontal disease | |
IL208607A0 (en) | Improved nanobodiestm for the treatment of aggregation-mediated disorders | |
GB0423554D0 (en) | Therapeutic compounds | |
IL179145A0 (en) | Therapeutic compounds | |
AP2006003669A0 (en) | Sulfonamide derivatives for the treatment of diseases | |
IL178815A0 (en) | The treatment of respiratory disease | |
EP1789034A4 (en) | Compounds with diphenoyl -structure for the treatment of immune diseases | |
GB0329874D0 (en) | Compounds useful for the treatment of diseases | |
GB0410399D0 (en) | The treatment of respiratory disease | |
GB0420424D0 (en) | Therapeutic compounds | |
HK1097831A1 (en) | Benzopyran compounds useful for the treatment of arrhytmia | |
GB0400802D0 (en) | Compounds for the treatment of disease | |
ZA200606780B (en) | Compounds for the treatment of diseases | |
GB0427138D0 (en) | Therapeutic compounds | |
GB0415352D0 (en) | Compounds for the treatment of disease | |
AP2006003743A0 (en) | Compounds useful for the treatment of diseases | |
GB0425064D0 (en) | Compounds useful for the treatment of diseases | |
GB0420867D0 (en) | Compounds for the treatment of diseases | |
GB0425073D0 (en) | Compounds for the treatment of diseases | |
IL177531A0 (en) | Compounds for the treatment of diseases | |
GB0423767D0 (en) | Therapeutic compounds | |
GB0417560D0 (en) | Therapeutic compounds | |
GB0315877D0 (en) | Compounds for the treatment of disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |